Izaak Walton Killam Health Centre: federal grants and contributions: 16 agreements; $9.0M value; 2 departments; 3 programs.
Assay record ASY-CA-0KZ6Z1516E · Cite as: Assay Systems, “Izaak Walton Killam Health Centre: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/izaak-walton-killam-health-centre/
Optimize eHealth-enabled service delivery platform for NICU
Low-dose radiographic imaging for paediatric ortho surgery
Development of a translational imaging cluster
Creation of a laboratory for Magnetoencephalography (MEG)
Acquisition of an animal PET-CT scanner
Establish a wet lab for sample processing and acquire a pre-clinical imaging system
Develop and market the Biomedical Translational Imaging Centre
Acquire equipment for NICU technology development
Acquire Quantum Design Helium Re-Liquefier to BIOTIC
Acquire Pre-Clinical SPECT for BIOTIC
Strategically located at the IWK Health Centre and the QEII Health Sciences Centre in Halifax. BIOTIC provides single-point access to the expertise, equipment, support services, clinicians, and patient populations needed to explore and validate potential new medical technologies as well as potential new therapeutic and diagnostic technologies. This project will provide access to IWK/BIOTICS’s highly specialized and unique technical medical imaging resources to benefit the needs of Canadian innovation SME companies. These services will strengthen the innovation R&D activity, resulting in accel
Strategically located at the IWK Health Centre and the QEII Health Sciences Centre in Halifax. BIOTIC provides single-point access to the expertise, equipment, support services, clinicians, and patient populations needed to explore and validate potential new medical technologies as well as potential new therapeutic and diagnostic technologies. This project will provide access to IWK/BIOTICS’s highly specialized and unique technical medical imaging resources to benefit the needs of Canadian innovation SME companies. These services will strengthen the innovation R&D activity, resulting in accele
The IWK Health Centre provides single-point access to the expertise, equipment, support services, clinicians, and patient populations needed to explore and validate potential new medical technologies as well as potential new therapeutic and diagnostic technologies. This project will provide access to IWK’s highly specialized and unique clinical resources to benefit the needs of Canadian innovation SME companies. These services will strengthen the innovation R&D activity, resulting in accelerated time to successful commercialization.
The IWK Health Centre provides single-point access to the expertise, equipment, support services, clinicians, and patient populations needed to explore and validate potential new medical technologies as well as potential new therapeutic and diagnostic technologies. This project will provide access to IWK’s highly specialized and unique clinical resources to benefit the needs of Canadian innovation SME companies. These services will strengthen the innovation R&D activity, resulting in accelerated time to successful commercialization.
The IWK Health Centre provides single-point access to the expertise, equipment, support services, clinicians, and patient populations needed to explore and validate potential new medical technologies as well as potential new therapeutic and diagnostic technologies. This project will provide access to IWK’s highly specialized and unique clinical resources to benefit the needs of Canadian innovation SME companies. These services will strengthen the innovation R&D activity, resulting in accelerated time to successful commercialization.
The IWK Health Centre provides single-point access to the expertise, equipment, support services, clinicians, and patient populations needed to explore and validate potential new medical technologies as well as potential new therapeutic and diagnostic technologies. This project will provide access to IWK’s highly specialized and unique clinical resources to benefit the needs of Canadian innovation SME companies. These services will strengthen the innovation R&D activity, resulting in accelerated time to successful commercialization.
Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.